Check Out What Whales Are Doing With IBRX
Portfolio Pulse from Benzinga Insights
Whales have shown a bearish stance on ImmunityBio (NASDAQ:IBRX), with unusual options activity indicating a split sentiment of 31% bullish and 69% bearish. The options trades suggest a price window of $1.5 to $15.0 for IBRX. Currently, IBRX's stock is down by -6.84%, trading at $8.38, with an RSI suggesting it may be approaching overbought territory. An analyst from Piper Sandler maintains a Neutral rating with a target price of $6.0.
April 30, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Unusual options activity and bearish sentiment among whales indicate potential volatility for IBRX. The stock is currently down, with an analyst maintaining a Neutral rating and a target price of $6.0.
The bearish sentiment among large investors, indicated by the unusual options activity, suggests that there may be concerns about IBRX's future performance. The current stock price decline and the analyst's Neutral rating with a target price below the current trading price further support the potential for short-term downside.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100